In vitro antimicrobial activity and resistance mechanisms of the new generation tetracycline agents, eravacycline, omadacycline, and tigecycline against clinical Staphylococcus aureus isolates

In vitro antimicrobial activity and resistance mechanisms of the new generation tetracycline agents, eravacycline, omadacycline, and tigecycline against clinical Staphylococcus aureus isolates

In this study, we investigated the in vitro activity and resistance mechanisms of the new generation tetracycline agents, namely eravacycline, omadacycline, and tigecycline, against Staphylococcus aureus isolates. A total of 1,017 non-duplicate S. aureus isolates were collected and subjected to susc...

Full description

Bibliographic Details
Main Authors:	Weiliang Zeng, Xiaotuan Zhang, Yan Liu, Yi Zhang, Mengxin Xu, Sipei Wang, Yao Sun, Tieli Zhou, Lijiang Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Microbiology
Subjects:	eravacycline omadacycline tigecycline Staphylococcus aureus antimicrobial activity resistance mechanisms
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2022.1043736/full

Similar Items

Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity In Vitro
by: Anqi Li, et al.
Published: (2023-06-01)

In Vitro Antimicrobial Activities of Tigecycline, Eravacycline, Omadacycline, and Sarecycline against Rapidly Growing Mycobacteria
by: Tingting Zhang, et al.
Published: (2023-02-01)

AdeABC Efflux Pump Controlled by AdeRS Two Component System Conferring Resistance to Tigecycline, Omadacycline and Eravacycline in Clinical Carbapenem Resistant Acinetobacter nosocomialis
by: Yi-Tzu Lee, et al.
Published: (2020-11-01)

Re-establishing the utility of tetracycline-class antibiotics for current challenges with antibiotic resistance
by: Kerry L. LaPlante, et al.
Published: (2022-12-01)

Evaluation of Neisseria gonorrhoeae Isolates Susceptibility to Tetracycline Antibiotics from 9 Provinces in China Since 2020
by: Zhou Q, et al.
Published: (2022-03-01)

Emergence of mobile tigecycline resistance mechanism in Escherichia coli strains from migratory birds in China
by: Chong Chen, et al.
Published: (2019-01-01)

In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018–2020
by: Po-Yu Liu, et al.
Published: (2022-10-01)

Novel Tet(L) Efflux Pump Variants Conferring Resistance to Tigecycline and Eravacycline in Staphylococcus Spp.
by: Nannan Wang, et al.
Published: (2021-12-01)

Efficacy and safety of eravacycline: A meta-analysis
by: Khalid Eljaaly, et al.
Published: (2021-03-01)

Eravacycline susceptibility was impacted by genetic mutation of 30S ribosome subunits, and branched-chain amino acid transport system II carrier protein, Na/Pi cotransporter family protein in Staphylococcus aureus
by: Zhanwen Wang, et al.
Published: (2020-07-01)

Novel Tetracyclines Versus Alternative Antibiotics for Treating Acute Bacterial Infection: A Meta-Analysis of Randomized Controlled Trials
by: Shao-Huan Lan, et al.
Published: (2019-11-01)

Antimicrobial activity of omadacycline in vitro against bacteria isolated from 2014 to 2017 in China, a multi-center study
by: Meng Xiao, et al.
Published: (2020-11-01)

The Novel Aminomethylcycline Omadacycline Has High Specificity for the Primary Tetracycline-Binding Site on the Bacterial Ribosome
by: Corina G. Heidrich, et al.
Published: (2016-09-01)

Mutations in the MepRAB efflux system contribute to the in vitro development of tigecycline resistance in Staphylococcus aureus
by: Renchi Fang, et al.
Published: (2020-09-01)

In vitro Activity and Heteroresistance of Omadacycline Against Clinical Staphylococcus aureus Isolates From China Reveal the Impact of Omadacycline Susceptibility by Branched-Chain Amino Acid Transport System II Carrier Protein, Na/Pi Cotransporter Family Protein, and Fibronectin-Binding Protein
by: Bing Bai, et al.
Published: (2019-11-01)

In vitro activities of Eravacycline against 336 isolates collected from 2012 to 2016 from 11 teaching hospitals in China
by: Chunjiang Zhao, et al.
Published: (2019-06-01)

The distribution of mutations and hotspots in transcription regulators of resistance-nodulation-cell division efflux pumps in tigecycline non-susceptible Acinetobacter baumannii in China
by: Qingye Xu, et al.
Published: (2020-12-01)

Antibacterial Activity of Eravacycline Against Carbapenem-Resistant Gram-Negative Isolates in China: An in vitro Study
by: Zou X, et al.
Published: (2023-04-01)

Tigecycline Resistance-Associated Mutations in the MepA Efflux Pump in Staphylococcus aureus
by: Honghao Huang, et al.
Published: (2023-08-01)

Omadacycline: A Newly Approved Antibacterial from the Class of Tetracyclines
by: Fernando Durães, et al.
Published: (2019-04-01)

Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant <i>Acinetobacter baumannii</i> Patient Isolates
by: Manas S. Deolankar, et al.
Published: (2022-09-01)

Activities of Eravacycline, Tedizolid, Norvancomycin, Nemonoxacin, Ceftaroline, and Comparators against 1,871 Staphylococcus and 1,068 Enterococcus Species Isolates from China: Updated Report of the CHINET Study 2019
by: Li Ding, et al.
Published: (2022-12-01)

Changes in Staphylococcus aureus susceptibility across Latin America between 2004 and 2010
by: Elvira Garza-González, et al.

Changes in Staphylococcus aureus susceptibility across Latin America between 2004 and 2010
by: Elvira Garza-González, et al.
Published: (2013-02-01)

Omadacycline for the treatment of Mycobacterium abscessus infections: Case series and review of the literature
by: Ayesha Siddiqa, et al.
Published: (2023-01-01)

In vitro susceptibility of common Enterobacterales to eravacycline in Taiwan
by: Chun-Fu Huang, et al.
Published: (2023-04-01)

Effect of omadacycline alone and in combination with meropenem against carbapenem-resistant Acinetobacter baumannii isolates
by: J. Nicholas O'Donnell, et al.
Published: (2022-06-01)

Empiric treatment approach for the management of post-operative incisional infections with omadacycline
by: Philip Wrotslavsky
Published: (2023-01-01)

A retrospective, multicentre evaluation of eravacycline utilisation in community and academic hospitals
by: Athena L.V. Hobbs, et al.
Published: (2022-06-01)

Surveillance of omadacycline activity tested against clinical isolates from the USA: report from the SENTRY Antimicrobial Surveillance Program, 2019
by: Michael A. Pfaller, et al.
Published: (2021-12-01)

Development of Resistance to Eravacycline by Klebsiella pneumoniae and Collateral Sensitivity-Guided Design of Combination Therapies
by: Congjuan Xu, et al.
Published: (2022-10-01)

Omadacycline Is Highly Active In Vitro against Mycoplasma genitalium
by: Ken B. Waites, et al.
Published: (2022-12-01)

Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022
by: Ashlan J. Kunz Coyne, et al.
Published: (2024-01-01)

In vitro Antimicrobial Activity and Dose Optimization of Eravacycline and Other Tetracycline Derivatives Against Levofloxacin-Non-Susceptible and/or Trimethoprim-Sulfamethoxazole-Resistant Stenotrophomonas maltophilia
by: Wu J, et al.
Published: (2023-09-01)

Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease
by: Binayak Rimal, et al.
Published: (2023-04-01)

Synergism of eravacycline combined with other antimicrobial agents against carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii
by: Yun Li, et al.
Published: (2022-09-01)

In Vitro Activity of KBP-7072 against 536 Acinetobacter baumannii Complex Isolates Collected in China
by: Renru Han, et al.
Published: (2022-02-01)

Comparative pharmacokinetics of chlortetracycline, tetracycline, minocycline, and tigecycline in broiler chickens
by: Hubert Ziółkowski, et al.
Published: (2020-10-01)

Mechanism of Eravacycline Resistance in Clinical Enterococcus faecalis Isolates From China
by: Zewen Wen, et al.
Published: (2020-05-01)

Omadacycline for treatment of acute bacterial infections: a meta-analysis of phase II/III trials
by: Fei Lin, et al.
Published: (2023-04-01)